Pharmaceuticals are leading the medical market for decades due to the over concentration on the biochemical interactions in the body. However, from an engineering point of view, the body is also a very intriguing, but complex connected and controlled electrical network. Electroceuticals will open the world of implanted electronic control functions for triggering various organs of the human body by the nervous system. It is estimated that electroceuticals will become a mainstay of medical treatment over the next two decades, benefiting up to 2 billion people who are suffering from chronic diseases. The research group will focus on novel electrical devices and the interaction mechanisms with the electrical network of organs. In a further extension, battery-free wireless opto-electronic devices for spinal optogenetics is another example of the electromagnetic control in a wider sense. Last but not least, the full potential of electroceuticals can also be extended to the field of bio-electromagnetism. The research group studies the impact of EM waves on different levels: system level (e.g. mice), on cellular, with emphasis on the mitochondrial level and finally at the molecular levels, e.g. enzymatic reactions or even on the diffusion of molecules in water. For more details of the EM control see the bio-electromagnetism section in the GHz-THz research domain.